Search research articles
Contact Us
Filters
Showing results (41-50 of 114) with videos related to
Page
of 12
Sort By:
Melanoma Research
|
February 22, 2022
Phase II study of apatinib combined with temozolomide in patients with advanced melanoma after failure of immunotherapy
Li Zhou, Yue Yang, Lu Si, et al.
BMC Cancer
|
May 19, 2026
Features of tumor microenvironment in HER2-positive urothelial carcinoma and its implications for immunotherapy resistance
Jiazhi Mo, Jiayuan Chen, Mengnan Qu, et al.
Journal of Cancer Research and Clinical Oncology
|
February 21, 2021
Real-world analysis of clinicopathological characteristics, survival rates, and prognostic factors in patients with melanoma brain metastases in China
Yang Wang, Bin Lian, Lu Si, et al.
Nucleic Acids Research
|
October 30, 2018
iDog: an integrated resource for domestic dogs and wild canids
Bixia Tang, Qing Zhou, Lili Dong, et al.
Translational Oncology
|
November 22, 2020
Chemotherapy combined with antiangiogenic drugs as salvage therapy in advanced melanoma patients progressing on PD-1 immunotherapy
Xuan Wang, Weiran Xu, Zhihong Chi, et al.
Genomics, Proteomics & Bioinformatics
|
October 8, 2023
OBIA: An Open Biomedical Imaging Archive
Enhui Jin, Dongli Zhao, Gangao Wu, et al.
Dermatology Practical & Conceptual
|
February 16, 2024
Pembrolizumab Versus High-Dose Interferon-α2b as Adjuvant Therapy for Pediatric Melanoma: A Retrospective Study
Yu Du, Zhonghui Qi, Xianbin Liang, et al.
Chinese Clinical Oncology
|
September 6, 2018
Palbociclib for treatment of metastatic melanoma with copy number variations of CDK4 pathway: case report
Bixia Tang, Xinan Sheng, Yan Kong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 20, 2017
<i>MAPK</i> Pathway and <i>TERT</i> Promoter Gene Mutation Pattern and Its Prognostic Value in Melanoma Patients: A Retrospective Study of 2,793 Cases
Xue Bai, Yan Kong, Zhihong Chi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 8, 2016
GNAQ and GNA11 mutations occur in 9.5% of mucosal melanoma and are associated with poor prognosis
Xinan Sheng, Yan Kong, Yiqian Li, et al.
Page
of 12
Search research articles
Search
Showing results (41-50 of 114) with videos related to
Sort By:
Page
of 12
Melanoma Research
|
February 22, 2022
Phase II study of apatinib combined with temozolomide in patients with advanced melanoma after failure of immunotherapy
Li Zhou, Yue Yang, Lu Si, et al.
BMC Cancer
|
May 19, 2026
Features of tumor microenvironment in HER2-positive urothelial carcinoma and its implications for immunotherapy resistance
Jiazhi Mo, Jiayuan Chen, Mengnan Qu, et al.
Journal of Cancer Research and Clinical Oncology
|
February 21, 2021
Real-world analysis of clinicopathological characteristics, survival rates, and prognostic factors in patients with melanoma brain metastases in China
Yang Wang, Bin Lian, Lu Si, et al.
Nucleic Acids Research
|
October 30, 2018
iDog: an integrated resource for domestic dogs and wild canids
Bixia Tang, Qing Zhou, Lili Dong, et al.
Translational Oncology
|
November 22, 2020
Chemotherapy combined with antiangiogenic drugs as salvage therapy in advanced melanoma patients progressing on PD-1 immunotherapy
Xuan Wang, Weiran Xu, Zhihong Chi, et al.
Genomics, Proteomics & Bioinformatics
|
October 8, 2023
OBIA: An Open Biomedical Imaging Archive
Enhui Jin, Dongli Zhao, Gangao Wu, et al.
Dermatology Practical & Conceptual
|
February 16, 2024
Pembrolizumab Versus High-Dose Interferon-α2b as Adjuvant Therapy for Pediatric Melanoma: A Retrospective Study
Yu Du, Zhonghui Qi, Xianbin Liang, et al.
Chinese Clinical Oncology
|
September 6, 2018
Palbociclib for treatment of metastatic melanoma with copy number variations of CDK4 pathway: case report
Bixia Tang, Xinan Sheng, Yan Kong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 20, 2017
<i>MAPK</i> Pathway and <i>TERT</i> Promoter Gene Mutation Pattern and Its Prognostic Value in Melanoma Patients: A Retrospective Study of 2,793 Cases
Xue Bai, Yan Kong, Zhihong Chi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 8, 2016
GNAQ and GNA11 mutations occur in 9.5% of mucosal melanoma and are associated with poor prognosis
Xinan Sheng, Yan Kong, Yiqian Li, et al.
Page
of 12